Ocelot Bio

CDMO focused on manufacturing of peptides

placeSan Diego, California, United States calendar_todayFounded 2020 groups20 employees language ocelotbio.com

Innovation

3 patent families — focus: Human necessities; filing pace accelerating. Cited 16 times.

YearFilings
20231
20242

Investor mix

3 investors on record; lead investors include Venrock, Vivo Capital, RA Capital Management.

Investor typeCountShare
Venture capital133%
Private equity133%
Other / undisclosed133%
Coming soon